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Abstract  
BACKGROUND: Neurosurgeons have preferred to perform the stereotactic biopsy for pathologic 
diagnosis when the intracranial pathology located eloquent areas and deep sites of the brain. 
AIM: To get a higher ratio of definite pathologic diagnosis during stereotactic biopsy and develop 
practical method. 
MATERIAL AND METHODS: We determined at least two different target points and two different 
trajectories to take brain biopsy during stereotactic biopsy. It is a different way from the 
conventional stereotactic biopsy method in which one point has been selected to take a biopsy. We 
separated our patients into two groups, group 1 (N=10), and group 2 (N= 19). We chose one target 
to take a biopsy in group 1, and two different targets and two different trajectories in group 2. In 
group 2, one patient underwent craniotomy due to hemorrhage at the site of the biopsy during 
tissue biting. However, none of the patients in both groups suffered any neurological complication 
related biopsy procedure.  
RESULTS: In group 1, two of 10 cases, and, in group 2, fourteen of 19 cases had positive biopsy 
harvesting. These results showed statistically significant difference between group 1 and group 2 
(P<0.05).  
CONCLUSIONS: Regarding these results, choosing more than one trajectories and taking at least 
six specimens from each target provides higher diagnostic rate in stereotaxic biopsy taking method.  
 
 
 
 
 
Introduction 
 
Stereotaxic biopsy taking method has been 
used to obtain a tissue diagnosis for intracranial 
lesions that are not possible to extract it from 
cerebrum, cerebellum or brainstem [1-5]. Moreover, 
this method is also applicable to patients who have 
not reserve to tolerate cranial surgery due to any 
systemic disease [6-8]. As well, in terms of technical 
aspects, stereotactic approach provide target 
specificity and precise targeting of any lesion within 
cranium, and it shows an accuracy ranging from 1.2 to 
2.8 mm [9-12]. Moreover, stereotactic needle biopsy 
has been used in daily neurosurgical practice because 
of the low complication ratio and high rate of 
diagnostic yield of this procedure [13-16]. Moreover, 
stereotactic brain biopsy gives positive results in 40- 
99 percent of cases [16-19].  
Different authors use combined one or more 
techniques to increase the positive results in their 
series [18-20]. Also, in a study, authors took more 
samples in number from the lesion during stereotactic 
brain biopsy than previous ones [19]. These authors 
took samples from the different zones of the lesion 
along one single trajectory of the probe, and they 
have had increased ratio of positive results from taken 
specimens [17-19]. In our cases, we decided to follow 
a little different procedure which was to take more 
tissue specimens by biopsy forceps in number from 
two separate targets and two distinct trajectories of 
the lesions. Moreover, we hypothesized that using 
different trajectories and taking more tissue samples 
numerically by biopsy forceps would give better 
results regarding diagnostic yield of this procedure. In 
this study, we investigated whether the higher number 
of tissue samples by biting (Number of the taken 
specimen by biopsy forceps) would result in higher 
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diagnostic rate. To provide this objective, we 
separated our patients into two groups regarding the 
number of the taken biopsy of each case. If the 
number of the taken biopsy was equal to ten or less 
than ten with one target and one trajectory line, these 
cases were included in group 1. Also, If the number of 
the taken biopsy was more than 10 with two targets 
and two trajectory lines, these cases were included to 
group 2. Additionally, group 1 consisted of 10 cases, 
and group 2 consisted of 19 cases. Lastly, we 
statistically compared our biopsy results and the 
number of taken samples from each patient in both 
groups. 
 
 
Materials and Methods 
 
We performed the biopsy procedure by an 
arc-based frame system (Fischer ZD, Germany). CT 
(Computerized Tomography) guided stereotactic 
biopsy was carried out on 29 patients at Baskent 
University Medical Faculty Department of 
Neurosurgery between 2008 and 2014. We selected 
our patients regarding their lesion location and the 
invasiveness of the lesion. Namely, if any lesion 
showed diffusely infiltrating features and it was 
located any eloquent areas - Heschyl gyrus, motor 
cortex, etc.-, we preferred to take stereotactic biopsy 
from those patients. Specifically, we decided to 
increase the number of taken biopsy and the 
trajectory for taking biopsy from each patient because 
of our low diagnostic ratio results. Firstly, we made 
cranial magnetic resonance imaging (MRI), and if the 
cranial MRI signs are in accordance with our criteria 
mentioning above, we perform cranial CT without 
contrast enhancement then with contrast 
enhancement. In addition, we compare MRI and CT 
findings. Then we decided whether to perform CT 
guided stereotactic biopsy. For example, if we identify 
the lesion in cranial MRI but not with cranial CT, we 
do not perform stereotaxic biopsy. Besides, we did not 
perform stereotactic biopsy in patients with severe 
neurologic deficit such as hemiplegia, aphasia 
dysphasia and patients showing increased intracranial 
pressure symptoms and signs of midline shift their CT 
or cranial MRI. Lastly, we excluded the patients with 
any blood coagulation problem. We showed the 
characteristics of the patients in Table 1 and 2.  
We firstly investigated abnormal density areas 
on cranial CT, and if we detected abnormal density 
areas correlating with contrast-enhanced areas of 
cranial MRI of the patient, we did not apply contrast-
enhanced cranial CT. However, we did not observe 
any abnormal density areas at the cranial CT. Then 
we performed contrast-enhanced cranial CT, and we 
compared it with contrast-enhanced cranial MRI. 
Finally, if we found any correlation between the cranial 
MRI and its corresponding CT, then we performed CT 
guided biopsy.  
Table 1: Characteristics of the Group 1. 
Cases Gender Age Number of  Taken Biopsy Results Pathologic Diagnosis Hemorrhage  
 Case 1 Male 61 8 Negative Insufficient Sampling No Hemorrhage 
 Case 2 Male 9 4 Negative Insufficient Sampling Hemorrhage * 
 Case 3 Female 60 8 Positive Malign Lymphoma No Hemorrhage 
 Case 4 Female 56 10 Negative Insufficient Sampling Hemorrhage * 
 Case 5 Female 52 10 Negative Insufficient Sampling Hemorrhage * 
 Case 6 Male 29 6 Negative Insufficient Sampling No Hemorrhage 
 Case 7 Male 59 6 Negative Insufficient Sampling No Hemorrhage 
 Case 8 Male 58 10 Positive Anaplastic Astrocytoma No Hemorrhage 
 Case 9 Female 52 10 Negative Insufficient Sampling Hemorrhage* 
 Case 10 Female 56 10 Negative Insufficient Sampling No Hemorrhage 
 
After determining eligibility of the patients for 
CT guided biopsy, we selected the target on the 
cranial CT for biopsy. We selected one target with one 
trajectory in group 1 and took the biopsies from 4 to 
10 in number by biopsy forceps.Furthermore, in group 
2, we selected two targets with two different 
trajectories on cranial CT with or without contrast-
enhanced CT. Moreover, we took the biopsies from 
each case from 11 to 39 in number by biopsy forceps 
in group 2. After biopsy taking, we send the 
specimens to the pathology department within saline 
physiologic solution. Of particular note, we never 
squeezed the specimen to prevent any damage to its 
texture. Pathologists at our institute decided on the 
pathologic diagnosis of the specimens.  
Table 2: Characteristics of the Group 2.  
Cases Gender Age Number of  Taken Biopsy Results Pathologic Diagnosis Hemorrhage  
 Case 1 Female 64 11 Negative Insufficient Sampling No Hemorrhage 
 Case 2 Female 49 15 Positive Glioblastoma Hemorrhage * 
 Case 3 Female 50 11 Positive Glioblastoma Hemorrhage * 
 Case 4 Female 53 12 Positive Grade 2 Astrocytoma Hemorrhage * 
 Case 5 Female 49 12 Positive Malign  Lymphoma No Hemorrhage 
 Case 6 Female 57 14 Negative Insufficient Sampling No Hemorrhage 
 Case 7 Female 78 20 Negative Insufficient Sampling No Hemorrhage 
 Case 8 Female 60 15 Positive Anaplastic Astrocytoma No Hemorrhage 
 Case 9 Female 29 36 Positive Grade 2 Astrocytoma No Hemorrhage 
 Case 10 Male 76 17 Positive Glioblastoma No Hemorrhage 
 Case 11 Male 28 39 Positive Malign Lymphoma Hemorrhage * 
 Case 12 Male 50 18 Negative Insufficient Sampling No Hemorrhage 
 Case 13 Male 57 29 Positive Glioblastoma Hemorrhage * 
 Case 14 Female 35 37 Positive Malign  Lymphoma Hemorrhage * 
 Case 15 Male 35 12 Negative Insufficient Sampling No Hemorrhage 
 Case 16 Female 71 13 Positive Glioblastoma No Hemorrhage 
 Case 17 Male 63 12 Positive Glioblastoma No Hemorrhage 
 Case 18 Male 53 14 Positive Anaplastic Astrocytoma No Hemorrhage 
 Case 19 Male 70 30 Positive Vasculitis Hemorrhage ** 
 
We presented the pathological diagnosis and 
surgery related complications in Table1 and 2. Also, 
preoperative and postoperative cranial CT and 
preoperative cranial MRI examples of different cases 
are shown in figures (Fig. 1 - Fig. 8). We evaluated 
histopathologic results with Chi-Square test using 
SPSS 11 (SPSS, Chicago, IL, USA) (Fig. 9). In 
addition, we used Student T-test to compare group 1 
and group 2 regarding the number of taken biopsy 
(Fig.10). Value of p < 0.05 was set to be statistically 
significant.  
 
 
Results 
 
The age of the 29 cases (15 females, 14 
males) ranged from 9 to 76 years. The average age of 
the patients, in group 1, 49.2 and theirs age standard 
deviation was 16.87. As well, in group 2, the mean 
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age of the patients was 54 and theirs age standard 
deviation was 14.80 (Table 1, 2). 
 
Statistical Analysis 
We evaluated histopathologic results with Chi-
Square test using SPSS 11 (SPSS, Chicago, IL, 
USA). In addition, we used Independent- Samples T-
test to compare group 1 and group 2 regarding the 
number of taken biopsy. Additionally, a value of p 
<0.05 was set to be statistically significant for both of 
the test (Fig. 9). Moreover, we found meaningful 
statistical difference between two groups regarding 
histopathologic results. Chi-Square test results 
showed that Pearson Chi-square value is 7.365 with 
one degree of freedom, and its asymptomatic 
significance is 0.006 (p<0.006). Also, we found 
meaningful statistical difference between two groups 
regarding taken by biopsy in number (P <0.001) (Fig. 
10).  
 
Histological Diagnosis  
We obtained pathologic diagnosis in two of 10 
cases in group 1, and one of them was anaplastic 
astrocytoma and the other one was malign lymphoma. 
Also, of the group 2, pathological diagnosis was 
obtained in fourteen of 19 cases. Moreover, six of 
them were glioblastoma, two of them were anaplastic 
astrocytoma, and two of them were low-grade 
astrocytoma, and three of them malign lymphoma and 
the last one was vasculitis. We showed the 
characteristics of in Table 1 and 2. 
 
Figure1 (Group 2, case 11): A, B, C - Contrast-enhanced 
(Gadolinium) T1 weighted cranial MRI in axial sections showing 
diffuse infiltrative multiple lesions around lateral ventricles and 
centrum semiovale. D, E, F - Contrast-enhanced (Metrizamide) 
cranial CT in axial sections showing weak contrast enhancement, 
and its contrast enhancing regions is corresponding with his MRI 
appearances. Note: This cranial CT was taken with a stereotactic 
frame before the operation.  
 
Complications 
We totally experienced bleeding while taking 
biopsy in eleven cases in both groups. Additionally, 
four of them in group 1 and 6 of them in group 2. We 
stopped the bleeding in 9 cases with pouring of the 
physiologic saline solution and aspirating it through 
stylet. Also, postoperative control CT showed no 
hematoma, but little hemorrhage at the site of the 
biopsy causing no mass effect and any sign or 
symptom related to this hemorrhage, in two cases in 
group 2 (Fig 2, Fig. 5). In both groups of the patients 
suffering from bleeding during biopsy, we use stylet to 
send physiologic saline as an irrigating solution to the 
region of biopsy to cease the bleeding. However, in 
one case that was from group 2, we had to make 
craniotomy stop bleeding because of the hematoma at 
the site of the biopsy (Fig.6-8). However, none of the 
patients in both groups had suffered from morbidity 
and mortality related to the biopsy procedure.  
 
Figure 2 A, B, C: Cranial CT following the procedure showing little 
amount of hemorrhage that is not caused any symptoms and signs.  
 
 
Discussion 
 
The biting capacity of the biopsy forceps – for 
taking samples from the cerebrum- may change 
regarding different manufacturers of these devices 
even with the same size of biopsy forceps [15]. 
Moreover, biopsy forceps is made of titanium and very 
tiny devices in order to prevent any complication while 
biting of the subcortical cerebral tissue [1-5]. So it can 
be easily changed its calibration of its mouth during 
the sterilization procedure and inappropriate using of it 
[15].  
 
Figure 3 (Group 2, case 8): A, B, C - Contrast-enhanced 
(Metrizamide) cranial CT in axial sections showing weak contrast 
enhancement at the insular region. Note: This cranial CT was taken 
with a stereotactic frame before the operation. D, E, F - Cranial CT 
following the procedure showing no hemorrhage. Also, this cranial 
CT showing two different target points with two different trajectories 
marked oval shaped hypodens areas at the centrum semiovale and 
around the insula on the left hemisphere. 
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Figure 4 (Group 2, Case 2): A, B, C - Contrast-enhanced 
(Gadolinium) T1 weighted cranial MRI in axial sections showing 
multiple hyperintense lesions at the anterior part of the frontal lobe 
of the left hemisphere. D, E, F - Contrast-enhanced (Metrizamide) 
cranial CT in axial sections showing weak contrast enhancement at 
the anterior part of the frontal lobe, and its contrast enhancing 
region is corresponding with his MRI appearances. Note: This 
cranial CT was taken with a stereotactic frame before the operation. 
 
Also, recently one of our biopsy forceps was 
broken in anyhow during the sterilization process. So 
changing of the calibration of the mouth during 
cleansing and sterilization may affect the biting 
capacity. Then this may cause insufficient volume of 
harvested tissue from the lesion within cerebrum [15]. 
Therefore, we developed a strategy to eliminate all of 
these drawbacks and to increase the positive rate of 
biopsy results. According to this strategy, we 
determined two different target points with two 
different trajectories to take a specimen, and we bited 
at least six times from each of the targets. Firstly, we 
thought that increased number of biting from the 
targets would cause more complication –hemorrhage- 
but it did not proceed what we would expect. In group 
1, consisting of ten patients, four of ten patients 
suffered from intracranial hemorrhage.  
 
Figure 5 A, B, C: Cranial CT in axial sections following the biopsy 
procedure showing very little amount of bleeding.  
 
Moreover, in group 2 (consisting of nineteen 
patients) six of them suffered from intracranial 
hemorrhage. Except one patient from group 2, we 
controlled the hemorrhage at the site of the biopsy by 
irrigating in both groups. However, we had to perform 
a craniotomy and evacuate the hematoma in one 
patient from group 2. This patient also showed good 
recovery and had no hemorrhage related signs and 
symptoms. In this case, we took 30 specimens to 
make a diagnosis. This patient would have been 
undergone chemotherapy with the diagnosis of brain 
lymphoma regarding cranial MRI findings if we had 
not taken biopsy. Moreover, this case received the 
diagnosis of central nervous system (CNS) vasculitis 
instead of lymphoma (Fig. 6-8).  
 
Figure 6 (Group 2, case 19): A, B, C - Contrast-enhanced 
(Gadolinium) T1 weighted cranial MRI in axial sections showing 
weak hyperintense lesions on the left parasagittal region of the 
centrum semiovale and around left lateral ventricular area. D, E, F - 
Cranial CT without contrast in axial sections showing hypodense 
areas on the left parasagittal region of the centrum semiovale and 
around left lateral ventricular region corresponding with hypodense 
areas of cranial MRI.  
 
We think that intracranial hemorrhage of this 
patient would have been developed due to this 
patient’s vasculitis rather than taking multiple biopsies 
from two different targets. We performed cranial MRI 
angiography and diffusion MRI in the early period of 
the bleeding and also seven months later. Both of 
them showed no injury to the major vasculature and 
infarct zone (Fig. 8). This finding also supports our 
notion that the hemorrhage ensued due to vasculitis. 
So our results showed better diagnostic results even 
increasing the risk of hemorrhage. However, we 
encountered increasing hemorrhage risk in group 2; 
none of the patients in group 2 has been suffered any 
hemorrhage related mortality and morbidity.  
 
Figure 7 A, B: Cranial CT of the axial sections showing hematoma 
at the left centrum semiovale after biopsy procedure; C, D: After 
hematoma evacuation. 
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The effectivity of the stereotactic biopsy is still 
under debate because of the inconclusive results of 
different studies. Some authors have claimed high 
diagnostic yield about the stereotactic biopsy [15-20]. 
However, a pathologic diagnosis could not be picked 
up approximately in 15 % of cases in others’ studies 
[12, 15-20].  
 
Figure 8: A, B, C - Cranial MR angiography showing no damage 
any arterial structures due to the biopsy procedure. D, E, F - Cranial 
MRI showing complete resorption of the hematoma 7 months later 
of the operation. 
 
Some authors mentioned the risks of 
nondiagnostic biopsy and listed those them as 
nonneoplastic lesions, deep lesions, small lesions and 
the lesions with very low contrast enhancement [12, 
15-21]. Besides in a study showed that the patients 
diagnosed with any pathology, 43.7% of whom 
needed to second biopsy because of progression or 
unresponsiveness to the treatment [12, 16-21]. So, 
surgeons intraoperatively would manage the 
diagnostic biopsy to prevent nondiagnostic or 
misdiagnostic results using some supplementary 
methods to increase the rate of positive pathologic 
diagnosis. For example, taking crush cytology and 
conventional histology of paraffin–embedded sections 
and frozen section, but the results of these methods 
also did not provide better results, according to 
previous studies [19-22]. 
 
Figure 9: Chi-Square test is showing statistically significant 
difference between group 1 and group 2 regarding histopathological 
results of the cases. 
 
Increasing the number of taken biopsy by 
biting to achieve better diagnostic results has already 
been reported [19]. The authors numerically took 
biopsies ranged between 1 and 6 bits from one 
trajectory, and The diagnostic accuracy increased 
from 76.5% for single biopsies to 84% and 88.2% for 
2 and 3 bits, respectively, and 100% for biopsies with 
5 to 6 bits. Thus, These results confirm that 
stereotactic claimed that procedures involving multiple 
bits result with a high diagnostic yield [19]. Moreover, 
some authors advocate that taking a biopsy from the 
center of the lesion would increase to hold positive 
result while making stereotactic biopsy from the 
cerebrum [20-23]. On the contrary, few authors 
advocate that taking biopsy from the center of the 
lesion would lead to misdiagnosing [22-24]. 
 
Figure 10: Independent sample Student T test is showing 
statistically significant difference between group 1 and group 2 
concerning the number of taken biopsy. 
 
From another point of view, a few of 
neoplasms show central necrosis, including 
glioblastoma, malignant lymphoma, and metastases 
[22-28]. In these cases, taking biopsy from the central 
target would cause necrotic or nondiagnostic tissue 
samples [22-28]. On the contrary, taking biopsy from 
the peripheral part of the lesions would cause 
sampling of gliotic tissue or normal cerebral tissue 
[22-24].  
Additionally, a few tumors show regionally 
homogeneous features, including metastatic 
carcinoma and melanoma, oligodendroglioma, 
ependymoma, primitive neuroectodermal tumor, 
meningioma, and malignant lymphoma [22-28]. In 
these tumors, neoplastic cells and reactive tissue 
intermingle due to regional homogenous feature of 
these tumors [22-28]. So, pathologic investigation of 
the biopsy taken from the local homogenous areas 
may result in gliosis or negative biopsy results [22-28]. 
In addition, failure of the recognition of the neoplastic 
cell type would cause a nondefinitive diagnosis of the 
taken biopsy [25-28]. 
Another facet of the nondefinitive diagnosis of 
the taken biopsy may be sampling limitations [23–25]. 
This is especially important for regionally 
heterogeneous neoplasms, including astrocytomas 
and germ cell neoplasms because the limited volume 
of the harvested tissue would hinder the exact 
diagnosis of the biopsy specimen [22-26]. As a result, 
higher grade astrocytoma is commonly 
underdiagnosed or misdiagnosed as lower- grade 
astrocytoma rather than higher grade astrocytoma 
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due to necrotic areas of the harvested biopsy tissue 
[26]. If the cranial MRI findings suggest higher grade 
astrocytoma, the biopsy result would show low-grade 
astocytoma. In these situations, the biopsy should be 
retaken from a different place to avoid misdiagnosis 
[24-26]. 
We offer to select two different target points 
and two different trajectories for taking biopsy 
because group 2 had higher diagnostic rate than that 
of group 1. Namely, fourteen of 19 patients had the 
pathologic diagnosis in group 2, but two of 10 patients 
in group 1 had the pathologic diagnosis. Moreover, we 
did not encounter any surgery related morbidity and 
mortality in both groups. However, in one case in 
group 2, the patient suffered from intracranial 
hemorrhage needed surgical evacuation. Also, this 
patient showed good recovery and no signs or 
symptoms related to this hemorrhage. These results 
showed that selection more than one point and taking 
at least six biopsies from each target would increase 
the positive pathologic harvesting.  
In brief, targeting at least two different points 
with two different trajectories and taking at least six 
samples from each target would help to improve the 
positive results. Moreover taking more samples would 
not cause more complications than that of the 
procedure taken biopsy less than ten samples from 
one target side.  
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